PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

Clinical trial NCT05652439 · RECRUITING

Trial details

NCT number: NCT05652439
Sponsor: Chiesi Farmaceutici S.p.A.
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2022-12-02
Primary completion: 2026-08-01
Enrollment: 25000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.